Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ruizhiyuan Ganoderma Cordyceps Capsules is an orally administered traditional Chinese medicine (TCM) supplement developed and manufactured by Shandong Zhirentang Pharmaceutical. The formulation combines extracts from Ganoderma lucidum (Lingzhi) and Cordyceps, which are traditionally used in East Asian medicine to promote longevity and vitality. The supplement is primarily marketed as a health food product in China, approved for its ability to enhance immune function and provide antioxidant protection. Its active constituents include Ganoderma polysaccharides, triterpenoids, and Cordyceps-derived compounds such as adenosine, which collectively work to support the body's natural defenses and overall physiological balance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ruizhiyuan Ganoderma Cordyceps Capsules.